Turkey - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Turkey Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry jumped by 3.1% year on year. In 2019, the country was number 23 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry at $231,137,855.44 Million PPP. Turkey is overtaken by Poland, which was number 22 with $268,990,772.83 Million PPP and is followed by Portugal with $178,795,494.19 Million PPP. United States lead the ranking with $70,565,318,932.39 Million PPP in 2019, +3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania witnessed the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 231,137,855.44 |
| 2018 | 224,359,946.73 |
| 2017 | 228,746,458.04 |
| 2016 | 176,819,251.10 |
| 2015 | 201,577,016.82 |
How does Turkey rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 22 |
#22
Poland
|
268,990,772.83 | 2019 | +5.0 % | +12.3 % | View data | |
| 23 |
#23
Turkey
|
231,137,855.44 | 2019 | +3.0 % | +3.1 % | View data | |
| 24 |
#24
Portugal
|
178,795,494.19 | 2019 | +3.3 % | +6.6 % | View data | |